Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Recent findings on the effects of marine-derived n-3 polyunsaturated fatty acids on urinary albumin excretion and renal function.

Lee CC, Adler AI.

Curr Atheroscler Rep. 2012 Dec;14(6):535-41. doi: 10.1007/s11883-012-0279-3. Review.

PMID:
22886495
2.

Time to abandon microalbuminuria?

Ruggenenti P, Remuzzi G.

Kidney Int. 2006 Oct;70(7):1214-22. Epub 2006 Jul 26. Review.

3.

Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.

Mulè G, Castiglia A, Cusumano C, Scaduto E, Geraci G, Altieri D, Di Natale E, Cacciatore O, Cerasola G, Cottone S.

Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85. Review.

PMID:
27873229
4.

[Cardio-renal interactions].

Ito S.

Nihon Rinsho. 2012 Sep;70(9):1562-70. Review. Japanese.

PMID:
23012804
5.

The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial.

Miller ER 3rd, Juraschek SP, Anderson CA, Guallar E, Henoch-Ryugo K, Charleston J, Turban S, Bennett MR, Appel LJ.

Diabetes Care. 2013 Jun;36(6):1462-9. doi: 10.2337/dc12-1940. Epub 2012 Dec 28.

6.

Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease.

Donadio JV Jr.

Mayo Clin Proc. 1991 Oct;66(10):1018-28. Review.

PMID:
1921484
7.

Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study.

Solbu MD, Jenssen TG, Eriksen BO, Toft I.

Metabolism. 2009 Mar;58(3):408-15. doi: 10.1016/j.metabol.2008.10.016.

PMID:
19217459
8.

Dietary α-Linolenic Acid, Marine ω-3 Fatty Acids, and Mortality in a Population With High Fish Consumption: Findings From the PREvención con DIeta MEDiterránea (PREDIMED) Study.

Sala-Vila A, Guasch-Ferré M, Hu FB, Sánchez-Tainta A, Bulló M, Serra-Mir M, López-Sabater C, Sorlí JV, Arós F, Fiol M, Muñoz MA, Serra-Majem L, Martínez JA, Corella D, Fitó M, Salas-Salvadó J, Martínez-González MA, Estruch R, Ros E; PREDIMED Investigators, B.

J Am Heart Assoc. 2016 Jan 26;5(1). pii: e002543. doi: 10.1161/JAHA.115.002543. Erratum in: J Am Heart Assoc. 2016 Feb;5(2). pii: e002077. doi: 10.1161/JAHA.116.002077.

9.

Long-term effects of linoleic-acid-enriched diet on albuminuria and lipid levels in type 1 (insulin-dependent) diabetic patients with elevated urinary albumin excretion.

Dullaart RP, Beusekamp BJ, Meijer S, Hoogenberg K, van Doormaal JJ, Sluiter WJ.

Diabetologia. 1992 Feb;35(2):165-72.

PMID:
1547922
10.

Importance of low-grade albuminuria.

Danziger J.

Mayo Clin Proc. 2008 Jul;83(7):806-12. doi: 10.4065/83.7.806. Review.

PMID:
18613997
11.

The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial.

Mori TA, Burke V, Puddey I, Irish A, Cowpland CA, Beilin L, Dogra G, Watts GF.

J Hypertens. 2009 Sep;27(9):1863-72.

PMID:
19705518
12.

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.

de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM.

Arch Intern Med. 2011 Mar 14;171(5):412-20. doi: 10.1001/archinternmed.2011.16.

13.

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.

Nettleton JA, Katz R.

J Am Diet Assoc. 2005 Mar;105(3):428-40. Review.

PMID:
15746832
14.

Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.

Abeywardena MY, Patten GS.

Endocr Metab Immune Disord Drug Targets. 2011 Sep 1;11(3):232-46. Review.

PMID:
21831036
15.

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.

PMID:
15799209
16.

Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.

Clase CM, Gao P, Tobe SW, McQueen MJ, Grosshennig A, Teo KK, Yusuf S, Mann JF; ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease).

Ann Intern Med. 2011 Mar 1;154(5):310-8. doi: 10.7326/0003-4819-154-5-201103010-00005.

PMID:
21357908
17.

Omega-3 fatty acids: role in cardiovascular health and disease.

Engler MM, Engler MB.

J Cardiovasc Nurs. 2006 Jan-Feb;21(1):17-24, quiz 25-6. Review.

PMID:
16407732
18.

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease.

Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P.

Clin J Am Soc Nephrol. 2008 Jul;3(4):976-85. doi: 10.2215/CJN.03960907. Epub 2008 Apr 16.

19.

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.

Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD.

N Engl J Med. 1996 Nov 28;335(22):1636-42.

20.

n-3 fatty acids and renal diseases.

De Caterina R, Endres S, Kristensen SD, Schmidt EB.

Am J Kidney Dis. 1994 Sep;24(3):397-415. Review.

PMID:
8079965

Supplemental Content

Support Center